Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Williams

Vascular Surgery Greenville, SC Medical Doctor

NPI 1962609347 CMS profile 1298185

3 Saint Francis Dr, Ste 330, Greenville, SC 29601

Open in the dashboard

General payments

$17,562

326 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Williams of Greenville, SC is reported in the CMS Open Payments database as having received $17,562 across 326 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,526 46
2024 General $2,296 51
2023 General $2,066 54
2022 General $2,984 48
2021 General $3,935 60
2020 General $1,981 26
2019 General $2,774 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Williams
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to David Williams were reported at $1,526. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year David Williams Vascular Surgery median Middle half National median
2019 $2,774 $796 $226–$2,363 $163
2020 $1,981 $348 $118–$1,110 $114
2021 $3,935 $471 $158–$1,421 $132
2022 $2,984 $725 $222–$2,183 $149
2023 $2,066 $836 $257–$2,440 $160
2024 $2,296 $909 $252–$2,619 $164
2025 $1,526 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $10,549 128 payments
  2. Bausch & Lomb, a division of Bausch Health US, LLC $1,942 20 payments
  3. Cook Medical LLC $1,126 19 payments
  4. Endologix, Inc. $519 5 payments
  5. Janssen Pharmaceuticals, Inc $519 31 payments
  6. CryoLife, Inc. $453 26 payments
  7. Organogenesis Inc. $380 14 payments
  8. Shockwave Medical, Inc $274 5 payments
  9. CVRx, Inc. $222 4 payments
  10. Medtronic, Inc. $176 4 payments
  11. Other $1,402 70 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $16,369 320 payments
  2. Travel and Lodging $1,193 6 payments
Products named General payments · program years 2019–2025
  1. enVista MX60 IOL $1,942 20 payments
  2. OPHTHALMIC INSTRUMENTS $1,871 19 payments
  3. Crystalens Accommodating IOL (AT-52AO) $1,871 19 payments
  4. GORE TAG Conformable Thoracic Endoprosthesis $1,813 18 payments
  5. Conformable TAG Thoracic Endoprosthesis $1,786 19 payments
  6. EXCLUDER Conformable AAA Endoprosthesis with Active Control $1,514 16 payments
  7. GORE VIABAHN VBX Balloon Expandable Endo $1,072 14 payments
  8. GORE EXCLUDER Iliac Branch Endoprosthesis $1,053 11 payments
  9. EXCLUDER Iliac Branch Endoprosthesis $848 10 payments
  10. GORE PROPATEN Vascular Graft $627 13 payments
  11. Other $8,609 271 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

35

Median for Vascular Surgery: 122

Drug cost

$208

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 35 $208

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$190,482

Medicare's payments for the services billed

Medicare patients

599

Average age 76

Services billed

1,589

224 women, 375 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 56%
Arthritis 53%
Chronic kidney disease 43%
Diabetes 42%
Atrial fibrillation 34%
Heart failure 28%
Depression 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $71
$71 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

326 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record